StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.24−0.16 (-6.67%)

Close on Nov 16, 2026Market cap $5.06MP/E –Yield –

How the market prices Biodexa Pharmaceuticals

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Biodexa Pharmaceuticals trades at 8.8× its earnings, against a median of 67.9× since 2016 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 67.9×, today 8.8×

What it earns on the capital it uses

Trailing twelve months over average capital

Return on capital employed-86.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by £3.23M. That is 539.6% of the £598.58K it would cost to buy the business outright.

Cash and short-term investments£3.23M
EBITDA, trailing twelve months-£8.65M
Free cash flow, trailing twelve months-£5.59M

Leverage and liquidity

Current ratio2.41
Quick ratio2.22

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-18.48
DistressGrey zoneSafe

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Free cash flow yield-146.1%
Buyback yield-359.1%
Shareholder yield-359.1%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

45
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

BDRXS&P 500
PeriodBDRXS&P 500DifferenceBDRX per yearS&P 500 per year
1 month+391.1%-3.1%+394.2 pts
3 months-81.6%-4.5%−77.1 pts
Year to date-97.5%+9.4%−106.9 pts
1 year-99.0%+11.3%−110.3 pts
3 years-100.0%+70.4%−170.4 pts-95.6%+19.4%
5 years-100.0%+68.6%−168.6 pts-96.1%+11.0%
10 years-100.0%+297.7%−397.7 pts-87.5%+14.8%

How much it moves

Volatility, 1 year2635.3%
Volume against its 90-day average0.01

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M BDRX shares were sold short on Oct 30, 2026, down 99.4% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 37.8% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.00

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,752-99.4%48,2131.0
Oct 15, 2026919,936+4905.1%7,171,8051.0
Sep 30, 202618,380-93.2%722,3701.0
Sep 15, 2026271,866+715.0%20,006,8701.0
Aug 31, 202633,356+593.2%1,671,3521.0
Aug 14, 20264,812-80.6%118,9011.0
Jul 31, 202624,819+150.0%319,9141.0
Jul 15, 20269,927-85.3%18,4241.0
Jun 30, 202667,330+759.2%399,3201.0
Jun 15, 20267,836-22.7%27,0111.0
May 29, 202610,140-51.5%16,9831.0
May 15, 202620,907+22.3%1,633,6331.0

Every measure, in full

48 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
£3.83M
–
Enterprise Value
£598.58K
–

Share statisticsIndustry

Shares Change (YoY)
1007.7%
–
Float
225.82B
–
Shares Held by Insiders
0.00%
–
Shares Held by Institutions
0.00%
–

Short sellingIndustry

Short Interest
5,752
–
Short Interest Change
-99.4%
–
Days to Cover
1.00
–

Stock price statisticsIndustry

Price Change (1 Week)
-8.94%
–
Price Change (1 Month)
391.1%
–
Price Change (3 Months)
-79.9%
–
Price Change (6 Months)
-91.1%
–
Price Change (YTD)
-97.5%
–
Price Change (1 Year)
-98.9%
–
Price Change (3 Years)
-100.0%
–
Price Change (5 Years)
-100.0%
–
Price Change (10 Years)
-100.0%
–
Average Volume (10 Days)
15,576
–
Average Volume (20 Days)
28,143
–
Average Volume (90 Days)
1M
–
Relative Volume
0.01
–
Relative Strength Index (14)
45.5
–
Volatility (1 Year)
2635.3%
–

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-86.9%
–

Financial positionIndustry

Current Ratio
2.41
–
Quick Ratio
2.22
–
Interest Coverage
-37.75
–

EfficiencyIndustry

Employee Count
12
–

Income statement (TTM)Industry

Operating Income
-£8.65M
–
Pretax Income
-£6.49M
–
EBITDA
-£8.65M
–
EPS (Diluted)
-0.00 GBP
–

Balance sheetIndustry

Net Cash (Debt)
£3.23M
–
Net Cash Per Share
0.00 GBP
–
Working Capital
£3.91M
–

Cash flow (TTM)Industry

Capital Expenditures
-£2.00K
–
Free Cash Flow
-£5.59M
–
FCF Per Share
-0.00 GBP
–

Dividends and yieldsIndustry

FCF Yield
-146.1%
–
Buyback Yield
-359.1%
–
Shareholder Yield
-359.1%
–

Taxes and interestIndustry

Interest Expense
£229.00K
–
Income Tax
-£105.00K
–

Scores and fair valueIndustry

Altman Z-Score
-18.48
–

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?